Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Tango Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/22/2023 3 Third Rock Ventures VI, L.P. (Director) has filed a Form 3 on Tango Therapeutics, Inc.
08/15/2023 4 Boxer Capital, LLC (See remarks) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Bought 475,000 shares @ $5.15, valued at $2.4M
Bought 2,340,579 options to buy @ $5.1499, valued at $12.1M
06/08/2023 4 Rothenberg Mace (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $3.55, valued at $106.5k
06/08/2023 4 Calhoun Lesley Ann (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $3.55, valued at $106.5k
06/08/2023 4 Borisy Alexis (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $3.55, valued at $106.5k
06/08/2023 4 Huber Reid M (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $3.55, valued at $106.5k
06/08/2023 4 Peters Malte (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $3.55, valued at $106.5k
06/08/2023 4 Davis Aaron I. (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0
Granted 30,000 options to buy @ $3.55, valued at $106.5k
03/02/2023 4 Crystal Adam (See Remarks) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 81,250 shares @ $0
Granted 487,500 options to buy @ $5.2, valued at $2.5M
03/02/2023 4 Weber Barbara (CEO) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 89,545 shares @ $0
Granted 537,273 options to buy @ $5.2, valued at $2.8M
03/02/2023 4 Beckman Daniella (CFO) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 32,842 shares @ $0
Granted 197,051 options to buy @ $5.2, valued at $1M
03/02/2023 4 Barry Douglas (General Counsel) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 23,898 shares @ $0
Granted 143,391 options to buy @ $5.2, valued at $745.6k
03/02/2023 3 Crystal Adam (See Remarks) has filed a Form 3 on Tango Therapeutics, Inc.
03/02/2023 4 Huang Alan (Chief Scientific Officer) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 31,697 shares @ $0
Granted 190,181 options to buy @ $5.2, valued at $988.9k
12/05/2022 4 Weitzman Aaron (Chief Medical Officer) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 350,000 options to buy @ $7.73, valued at $2.7M
12/05/2022 3 Weitzman Aaron (Chief Medical Officer) has filed a Form 3 on Tango Therapeutics, Inc.
10/13/2022 4 Boxer Capital, LLC (10% Owner) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Bought 117,000 shares @ $4.2539, valued at $497.7k
Bought 50,000 shares @ $4.4328, valued at $221.6k
Bought 70,000 shares @ $4.6461, valued at $325.2k
10/06/2022 4 Boxer Capital, LLC (10% Owner) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Bought 25,606 shares @ $3.6701, valued at $94k
Bought 45,500 shares @ $3.9262, valued at $178.6k
Bought 40,500 shares @ $3.8373, valued at $155.4k
Bought 70,394 shares @ $4.0638, valued at $286.1k
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Peters Malte (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $5.9, valued at $236k
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Rothenberg Mace (Director) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $5.9, valued at $236k
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2022 3 Braslyn Ltd. (10% Owner) has filed a Form 3 on Tango Therapeutics, Inc.
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
11/03/2021 4 Rudoltz Marc (Chief Medical Officer) has filed a Form 4 on Tango Therapeutics, Inc.
Txns: Granted 350,000 options to buy @ $12.91, valued at $4.5M
11/01/2021 3 Rudoltz Marc (Chief Medical Officer) has filed a Form 3 on Tango Therapeutics, Inc.
11/01/2021 3 Barry Douglas (See Remarks) has filed a Form 3 on Tango Therapeutics, Inc.
08/20/2021 3 BCTG Holdings, LLC (10% Owner) has filed a Form 3 on Tango Therapeutics, Inc.
08/20/2021 3 Boxer Capital, LLC (10% Owner) has filed a Form 3 on Tango Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy